Reduction in cytokine production in colorectal cancer patients: Association with stage and reversal by resection

British Journal of Cancer

Volumn 82, Issue 5, 2000, Pages 1009-1012

  Heriot, A G ^a   Marriott, J B ^a   Cookson, S ^a   Kumar, D ^a   Dalgleish, A G ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Colorectal cancer; Cytokines; Immune suppression

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CULTURE; BLOOD LEVEL; CANCER STAGING; CANCER SURGERY; CELL FUNCTION; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; VENOUS BLOOD;

EID: 0034092903     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1034     Document Type: Article

References (17)

1. Arista M, Callopoli A, De Franceschi L, Santini A, Schiratti M, Di Filippo F and Gandolfo GM (1994) Flow cytometric study of lymphocyte subsets in patients at different stage of colorectal carcinoma. Dis Colon Rectum 37: S30-4
2. Barni S, Lissoni P, Cazzaniga M, Ardizzoia A, Meregalli S, Fossati V, Fumagalli L, Brivio F and Tancini G (1995) A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates. Oncology 52: 243-245
3. Brivio F, Lissoni P, Alderi G, Barni S, Lavorato F and Fumagalli L (1996) Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology 53: 263-268
4. Cole W and Humphrey L (1985) Need for immunologic stimulators during immunosuppression produced by major cancer surgery. Ann Surg 202: 9-20
5. Darcy P, Kershaw M, Trapani J and Smyth M (1998) Expression in cytotoxic T lymphocytes of a single chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma. Eur J Immunol 28: 1663-1672
6. Elsasser Beile U, von Kleist S, Fischer R and Monting JS (1992) Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J Clin Lab Anal 6: 311-314
7. Hammer J, Nielsen H, Moesgaard F and Kehlet H (1992) Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests. Eur Surg Res 24: 133-137
8. Hrouda D, Muir G and Dalgleish A (1997) The role of immunotherapy for urological tumours. Br J Urol 79: 307-316
9. King J, Caplehorn J, Ross W and Morris D (1997) High serum carcinembryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive of survival. Br J Surg 84: 1382-1385
10. McMillan DC, Fyffe GD, Wotherspoon HA, Cooke TG and McArdle CS (1997) Prospective study of circulating T-lymphocyte subpopulations and disease progression in colorectal cancer. Dis Colon Rectum 40: 1068-1071
11. Medical Oncology Society (1979) Delayed cutaneous hypersensitivity (DCH) reactions in normal populations by multitest; effect of sex and age. 5th Annual Meeting of the Medical Oncology Society, 1-3 December, Nice, France. Springer: Berlin
12. Mittelman A, Huberman M, Puccio C, Fallon B, Tessitore J, Savona S, Eyre R, Gafney E, Wick M, Skelos A, et al (1990) A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer and malignant melanoma. Cancer 66: 664-669
13. O'Hara R, Greenman J, Drew P, McDonald AW, Duthie GS, Lee PW and Monson JR (1998) Impaired interleukin-12 production is associated with a defective anti-tumor response in colorectal cancer. Dis Colon Rectum 41: 460-463
14. Pullyblank A, Guillou P and Monson J (1991) Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody dependent cell-mediated cytotoxity. Br J Cancer 72: 601-606
15. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group [see comments]. Lancet 343: 1177-1183
16. Tancini G, Barni S, Rescaldani R, Fiorelli G, Viviani S and Lissoni P (1990) Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms. Oncology 47: 381-384.
17. Tsutsui S, Morita M, Kuwano H, Matsuda H, Mori M, Okamura S and Sugimachi K (1992) Influence of preoperative treatment and surgical operation on immune function of patients with oesophageal carcinoma. J Surg Oncol 49: 176-181